An Integrative Study on the Inhibition of Bone Loss via Osteo-F Based on Network Pharmacology, Experimental Verification, and Clinical Trials in Postmenopausal Women

The inhibition of bone loss remains a challenge for postmenopausal women, considering the fact that only three anabolic treatments for osteoporosis have been approved by the FDA. This study aimed to investigate the osteogenic capacities of Osteo-F, a newly developed herbal formula, upon integrating...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Mi Hye, Bok, Minkyung, Lim, Hyunjung, Yang, Woong Mo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417279/
https://www.ncbi.nlm.nih.gov/pubmed/37566071
http://dx.doi.org/10.3390/cells12151992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417279/
https://www.ncbi.nlm.nih.gov/pubmed/37566071
http://dx.doi.org/10.3390/cells12151992

Ejemplares similares